Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study-Reference-Cited by-同舟云学术

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating ‘valvular heart disease’ in a nationwide cohort study

Published:2018-07-06 Issue:1 Volume:21 Page:33-40
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Lip Gregory Y H¹²,Jensen Martin¹³,Melgaard Line¹⁴,Skjøth Flemming¹³,Nielsen Peter Brønnum¹⁴,Larsen Torben Bjerregaard¹⁴

Affiliation:

1. Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Faculty of Health, Aalborg University, Aalborg, Denmark

2. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

3. Unit of Clinical Biostatistics, Aalborg University Hospital, Aalborg, Denmark

4. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark

Funder

Obel Family Foundation

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/21/1/33/27387154/euy151.pdf

Reference18 articles.

1. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making;Lip;Thromb Haemost,2017

2. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE);Lip;Europace,2017

3. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation;Lip;Chest,2010

4. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation;Pisters;Chest,2010

5. Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study;Chao;Int J Cardiol,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension and Abnormal Renal Function and the Risk of Ischaemic Stroke in Anticoagulated Type 1 Evaluated Heart Valves, Rheumatic or Artificial Valvular AF;Journal of Asian Pacific Society of Cardiology;2024-07-11

2. Longitudinal Analysis of Predictive Factors for Stroke and Bleeding Events in Atrial Fibrillation Patients: Insights From a Tertiary Care Center Cohort;Cureus;2024-05-02

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

4. Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program;Clinical and Applied Thrombosis/Hemostasis;2024-01

5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01